Examining the properties and therapeutic potential of glial restricted precursors in spinal cord injury529-533
The choroid plexus-cerebrospinal lfuid interface in Alzheimer’s disease：more than just a barrier534-537
Physical interactions between activated microglia and injured axons:do all contacts lead to phagocytosis?538-540
Counteraction of Nogo-A and axonal growth inhibitors by green tea polyphenols and other natural products545-546
Analysis of lfuoxetine-induced plasticity mechanisms as a strategy for understanding plasticity related neural disorders547-548
